Authors: Mehnert, H

Citation: H. Mehnert, Classification of diabetes mellitus, DEUT MED WO, 126(24), 2001, pp. 737-738

Authors: Mehnert, H

Citation: H. Mehnert, Metformin, the rebirth of a biguanide: mechanism of action and place in the prevention and treatment of insulin resistance, EXP CL E D, 109, 2001, pp. S259-S264

Authors: Mehnert, H

Citation: H. Mehnert, The United Kingdom Prospective Diabetes Study (UKPDS) a year later: diabetological realities and desiderata, DEUT MED WO, 124(36), 1999, pp. 1021-1021

Authors: Reljanovic, M Reichel, G Rett, K Lobisch, M Schuette, K Moller, W Tritschler, HJ Mehnert, H

Citation: M. Reljanovic et al., Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II), FREE RAD RE, 31(3), 1999, pp. 171-179

Authors: Ziegler, D Reljanovic, M Mehnert, H Gries, FA

Citation: D. Ziegler et al., alpha-Lipoic acid in the treatment of diabetic polyneuropathy in Germany: Current evidence from clinical trials, EXP CL E D, 107(7), 1999, pp. 421-430

Authors: Ruhnau, KJ Meissner, HP Finn, JR Reljanovic, M Lobisch, M Schutte, K Nehrdich, D Tritschler, HJ Mehnert, H Ziegler, D

Citation: Kj. Ruhnau et al., Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy, DIABET MED, 16(12), 1999, pp. 1040-1043